News | February 07, 2007

Michigan Hospitals Commit to Faster D2B

Feb 9, 2007 —A new multihospital initiative began in Michigan this week that will rush faster treatment to the state’s residents who suffer heart attacks. Thirty-five hospitals are banning together as part of a statewide project coordinated by the Michigan Chapter of the American College of Cardiology and the University of Michigan Cardiovascular Center with support from Blue Cross Blue Shield of Michigan/Blue Care Network.

Goal No. 1 is to reduce the time it takes to deliver heart-attack care — from the minute a patient arrives at the emergency room to the minute doctors deploy artery-opening balloons to restore blood flow through the blocked vessels that cause most heart attacks.

“Every minute that can be saved is critical, because it keeps a bit of the patient’s heart muscle from dying or being weakened by lack of oxygen,” says U-M’s Mauro Moscucci, M.D., who will help lead the project. “In other words, time is muscle.”

“This is an example of a health plan, hospitals and doctors working together to make our state a national leader in improving the quality and efficiency of heart attack care,” says Thomas Simmer, M.D., BCBSM senior vice president and chief medical officer.

The effort represents a large-scale implementation of ACC’s national campaign called “Door to Balloon: An Alliance for Quality.” Many other health organizations including The American Heart Association are project partners.

Michigan has a jump-start on the national effort because of previous statewide efforts to help hospitals improve other aspects of heart care, and D2B times. Under the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) (www.bmc2.org) led by Moscucci and BCBSM’s David Share, M.D., and coordinated by Eva Kline-Rogers, RN, MS, a group of 17 Michigan hospitals have been working to improve their angioplasty practices.

Michigan is already ahead of the national curve on D2B times, though its hospitals still have room for improvement. Current Medicare data show that 71 percent of Michigan heart attack patients get their angioplasty within 120 minutes of arrival — far better than the national average of 56 percent.

The national and Michigan efforts are both aiming to get D2B time down to 90 minutes or less for at least 75 percent of patients experiencing the most common type of heart attack, called STEMI for ST-elevated myocardial infarction. Only STEMI patients have been shown to receive more benefit from emergency angioplasty — which is also known as primary percutaneous coronary intervention or primary PCI — than from fibrinolytic (clot-busting) drugs that can be given at most hospitals.

Related Content

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI)| August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
Cardiac CT scan showing plaque and calcification in the coronary arteries, from a Toshiba CT scanner
News | Business| July 19, 2017
July 19, 2017 — The Society of Cardiovascular Computed Tomography (SCCT) created a reimbursement fee chart for cardia
German Workshop Highlights Possibilities of Perfusion MRI
News | Stroke| July 03, 2017
When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Toshiba Medical Introduces Vantage Titan Zen Edition MR
Technology | Magnetic Resonance Imaging (MRI)| June 27, 2017
June 27, 2017 — Toshiba Medical, a Canon Group company, introduced its newest...
HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices
Feature | May 15, 2017
May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States o
Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 10, 2017
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm...
Toshiba Showcases Vantage Galan 3T MRI at ISMRM 2017
News | Magnetic Resonance Imaging (MRI)| April 24, 2017
April 24, 2017 — Offering a full range of advanced clinical applications for researchers, Toshiba Medical will demons
Overlay Init